Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Evaxion Biotech A/S Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.71 | -$0.71 | -$0.71 |
| Q2 2025 | 2 | -$0.66 | -$0.50 | -$0.58 |
| Q3 2025 | 1 | -$0.59 | -$0.59 | -$0.59 |
| Q4 2025 | 1 | -$0.61 | -$0.61 | -$0.61 |
| Q1 2026 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q2 2026 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q3 2026 | 1 | -$0.65 | -$0.65 | -$0.65 |
| Q4 2026 | 1 | -$0.70 | -$0.70 | -$0.70 |
Evaxion Biotech A/S Earnings Date And Information
Evaxion Biotech A/S last posted its earnings results on Tuesday, May 27th, 2025. The company reported $-0.29 earnings per share for the quarter, topping analysts' consensus estimates of $-0.65 by $0.36. The company had revenue of 0 for the quarter and had revenue of 3.34 M for the year. Evaxion Biotech A/S has generated $-2 earnings per share over the last year ($-2 diluted earnings per share) and currently has a price-to-earnings ratio of -1.02. Evaxion Biotech A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based on prior year's report dates.
Evaxion Biotech A/S Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 2025 | N/A | -$0.29 | N/A | $60.00 K | $0 |
| 04/01/2025 | Q4 2024 | N/A | -$0.68 | N/A | $1.66 M | $122.00 K |
| 09/30/2024 | Q3 2024 | N/A | -$0.28 | N/A | $123.33 K | $3.03 M |
| 06/30/2024 | Q2 2024 | N/A | -$0.91 | N/A | $52.00 K | $153.89 K |
| 08/14/2024 | Q1 2024 | $0.10 | $0.21 | 0.11 | $37.00 K | $50.88 K |
| 03/26/2024 | Q4 2023 | N/A | -$1.34 | N/A | N/A | $73.60 K |
| 09/30/2023 | Q3 2023 | N/A | -$1.64 | N/A | N/A | $0 |
| 08/17/2023 | Q2 2023 | N/A | -$1.68 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$1.94 | N/A | N/A | $0 |
| 04/27/2023 | Q4 2022 | N/A | -$2.28 | N/A | N/A | $0 |
| 11/13/2022 | Q3 2022 | -$17.00 | -$1.93 | 15.07 | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$1.64 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$2.00 | N/A | N/A | $0 |
| 03/31/2022 | Q4 2021 | N/A | -$3.09 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$2.18 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$2.88 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$1.84 | N/A | N/A | $0 |
| 04/07/2021 | Q4 2020 | N/A | -$2.10 | N/A | N/A | $0 |
| 09/30/2020 | Q3 2020 | N/A | -$1.98 | N/A | N/A | $0 |
| 06/30/2020 | Q2 2020 | N/A | -$1.52 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Evaxion Biotech A/S Earnings: FAQ's
Evaxion Biotech A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based offlast year's report dates.
In the previous quarter, Evaxion Biotech A/S (:EVAX) reported $-0.29 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.65 by $0.36.
The conference call for Evaxion Biotech A/S's latest earnings report can be listened to online.
The conference call transcript for Evaxion Biotech A/S's latest earnings report can be read online.
Evaxion Biotech A/S (:EVAX) has a recorded annual revenue of $3.34 M.
Evaxion Biotech A/S (:EVAX) has a recorded net income of $-10,567,000.Evaxion Biotech A/S has generated $-2 earnings per share over the last four quarters.
Evaxion Biotech A/S (:EVAX) has a price-to-earnings ratio of -1.02 and price/earnings-to-growth ratio is 0.03.